TEACHABLE MEDICAL NEWS

CREATED BY ELEASYS LLC

Tag: antibody

Can we chase down and kill the hiding cancer cells in our bodies?

By

On August 25, 2025

In lymphatic and immune system

Teachable moment in classrooms:

  1. cellular basis of life chapter – DNA specifies protein structure
  2. blood chapter – role of red bone marrow in hemopoesis
  3. immune system chapter – development of T and B cells and their role in the immune response
  4. immune system chapter – structure of antibodies and their binding to specific target molecules

The news item:  Recently the following news item appeared online:

Talvey Giving Patients With Heavily Pretreated Multiple Myeloma ‘a New Lease on Life’

The recent FDA approval of Talvey for heavily pretreated multiple myeloma results in an improved response to therapy and a manageable side effect profile.

The report describes that the Talvey treatment is given to multiple myeloma patients whose cancer returned despite several previous treatment with conventional drugs. The report also describes the several side effects of Talvey treatment.

So, Why Do I Care??  Every year multiple myeloma kills over 12,000 people in the USA alone. This type of cancer frequently reappears after conventional cancer treatments, and any new treatment that extends patient life after previous treatments are exhausted, is important to research.

Plain English, Please!!! First, let’s talk about what multiple myeloma is. This disorder represents a cancerous, uncontrolled cell division of plasma cells in the red bone marrow. A plasma cell is a type of white blood cell that produces antibodies during immune response. When the cancerous plasma cells quickly multiply and overtake the red bone marrow, fewer red blood cells and platelets are made, leading to fatigue, tiredness and easy bleeding.

Second, let’s talk about how Talvey works. If we want the immune system to kill cancer cells it would make sense to bring the immune system’s cells right to the cancer cells. Metaphorically speaking, picture

Read More

How can the pharmaceutical Leqembi slow the progression of Alzheimer’s disease?

By

On October 29, 2024

In lymphatic and immune system, nervous system

Teachable moment in classrooms:

  1. nervous system chapter – functions of neurons
  2. nervous system chapter – function of synapses in neuronal communication
  3. immune system chapter – role of antibodies to speed up phagocytosis
  4. blood chapter – function of neutrophils, monocytes and macrophages

The news item:  Recently the following report appeared online:

First Alzheimer’s drug to slow disease, Leqembi, gets full FDA approval

Leqembi is not a cure, but it is the first drug shown to slow the progression of Alzheimer’s disease. It first received an accelerated approval from the FDA earlier this year.

The article states that Leqembi slows the progression of Alzheimer’s disease in early stage Alzheimer’s patients, because Leqembi can remove the disease-causing plaques from the brain, and prevent their formation. The article also states that the plaques prevent neurons from talking to each other.

So, Why Do I Care??  Alzheimer’s disease (dementia) affects almost 7 million people in the USA. The memory loss at first  reduces the quality of life, and then makes the patients dependent on daily nursing care. All the while the patients no longer recognize family members, or items in their environment, making it difficult on the families. Because there is no effective treatment or prevention for it, pharmaceuticals even with moderate effectiveness can have positive impact on both the patients and the families.

Plain English, Please!!!

First, let’s talk about what Alzheimer’s disease is. Recalling memories is a function assigned to groups of neurons, sometime called neuronal circuits. Each circuit may have thousands or millions of neurons, and the communication between the members keep the circuit functioning. Each time you remember something, neurons of a memory circuit are activated. Think about the “wave” you see in sporting events where the spectators stand up and raise their arms and then sit down forming a moving “wave. Each spectator is a neuron, and their collective action produces a “wave”, the recalling of a memory. In Alzheimer’s disease the neurons of the memory circuits malfunction, and when those neurons try to act in a coordinated fashion, their activity, their “wave”, their recall of memory becomes weaker leading to loss of memory. A few years into the disease large number of neurons may malfunction and die and complete the loss of memory may happen.

Second, let’s talk about why neurons are thought to die in Alzheimer’s disease. The most widely accepted theory is that the buildup of clumps of amyloid peptide, also called senile plaques, outside the neurons

Read More

Can we use an antibody to strengthen patients’ own immune system to fight childhood soft tissue cancer?

By

On December 18, 2023

In cellular basis of life, lymphatic and immune system, tissues

Teachable moment in classrooms:

  1. tissue chapter – general characteristics of epithelial and connective tissues
  2. cellular basis of life chapter – proteins in cell membranes can serve as receptors
  3. immune system chapter – CD8-T-cells actively destroy target cells
  4. immune system chapter – antibodies can be engineered to bind to specific targets

The news item:

Recently a newly approved treatment for childhood soft tissue cancer was reported:

Drug Approved to Help Young Patients Battle a Rare Cancer

US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.

The article states that the drug Tecentriq was approved for use against alveolar soft part sarcoma (a soft tissue cancer). About 80 children and adults in the USA are diagnosed each year with his sarcoma, and most conventional treatments fail to fight it. The article also states that Tecentriq is an anti-PD-L1 inhibitor, and works by helping the immune system respond more strongly to cancer.

So, Why Do I Care??  While the overall number of cancer patients diagnosed with alveolar soft part sarcoma is low, these patients could not be helped by regular cancer treatments. Finding new cancer treatment approaches for these patients opens the possibility to treat other cancers where traditional cancer treatment failed.

Plain English, Please!!!  First, let’s talk about what a sarcoma is. The sarcoma type of cancers start from connective tissue, as opposed to the carcinoma type of cancers that start from epithelial tissues. The general course of the sarcomas is similar to other cancers, and that includes local growth, and the spreading, metastasizing throughout the body. Alveolar soft part sarcoma was named such, because the cancer cells form baggy, alveolus-looking microscopic structures.

Second, let’s talk about how cancer cells can slow down the immune system. One normal function of our immune system is to detect and destroy cells that show evidence of infection or abnormal components.

Read More

Could antibodies from plasma of recovered patients defeat the SARS-CoV-2 virus?

By

On June 4, 2020

In lymphatic and immune system, respiratory system

TeachableMedicalNews article 06042020

Teachable moment in classrooms:

  1. cell chapter – endocytosis and phagocytosis as transport through cell membranes
  2. blood chapter – white blood cell types and their functions
  3. respiratory system chapter – alveoli as the sites of gas exchange
  4. respiratory system chapter – macrophages of alveoli
  5. lymphatic and immune system chapter – antibody structure
  6. lymphatic and immune system chapter – antibodies are made for specific targets

The news item:  Recently reports appeared where blood plasma taken from recovered patients are given to seriously ill COVID-19 patients:

Blood plasma appears safe for COVID-19 patients in early trial results

Researchers report promising results in early safety trials of convalescent plasma therapy, in which the blood of COVID-19 survivors is used to treat patients.

The article mentions that antibodies in the plasma are the active ingredient, and that 5000 patients were evaluated in this trial to determine the safety of such treatment.

So, Why Do I Care??  Have you been living under a rock in the last few months??? The coronavirus, SARS-CoV-2, responsible for the COVID-19 disease has so far infected over 6 million people, and caused over 377,000 deaths worldwide (on the date of this article). The virus attacks the respiratory system, specifically the alveoli, and may cause pneumonia and death by respiratory failure.  The antibodies from the recovered patients hold promise as a possible treatment to lower the lethality of the virus.

Read More

Can an ancient disease cancel a Phish concert?

By

On March 5, 2020

In cellular basis of life, lymphatic and immune system

TeachableMedicalNews article 03052020

Teachable moment in classrooms:

  1. cellular basis of life chapter – endocytosis as cellular transport
  2. immune system chapter – phagocytosis by the cells of the innate immune system
  3. immune system chapter – activation of the B cells by macrophages in the adaptive immune system
  4. immune system chapter – antibodies speed up phagocytosis of invading microbes
  5. microbiology —  pathology of Yersinia pestis bacterium

The news item:  Recently the disease called plague was reported to disrupt camping and other preparation for a Phish concert in Denver:

Plague-ridden prairie dogs force cancellation of Phish camping event

This is probably not what Phish had in mind when they wrote their 1994 single, “Down with Disease.” Self-proclaimed “Phans” of the legendary jam band are singing the blues a…

The article mentioned that prairie dogs were infected with the plague, and there was concern that the plague would be passed on to concert goers.

Read More

Don’t want to get Salmonella infection? Wash your hand after handling pig ears!

By

On January 21, 2020

In cellular basis of life, digestive system, lymphatic and immune system

TeachableMedicalNews article 01212020

Teachable moment in classrooms:

  1. cellular basis of life chapter – function of lysosomes
  2. digestive system chapter – HCl in gastric juice kill bacteria
  3. immune system chapter – cytotoxic T cells destroy infected cells
  4. immune system chapter – antibody production by plasma cells
  5. microbiology; human pathogenic bacteria

 The news item:  Hospitalization of over 100 people from Salmonella infection was in the news recently.

Read More

Can an injectable treatment work for migraines?

By

On July 31, 2019

In lymphatic and immune system, nervous system

TeachableMedicalNews article 07312019

Teachable moment in classrooms:

  1. general senses chapter – unconventional types of pain
  2. general senses chapter – pharmaceuticals in of pain control
  3. immune system chapter – antibodies as pharmaceuticals

 

Can an injectable treatment work for migraines?

 The news item:  New injectable preventions and treatments for migraine were in the news recently. One of them is Aimovig (erenumab):

FDA approves new drug that stops chronic migraines

The FDA approves, Erenumab, a new migraine treatment, that blocks chronic and disabling headaches, without causing many side effects.

The article mentions migraine statistics, the calcitonin gene related peptide (CGRP) as the culprit in migraines, and that the new drug is an antibody.

 

So, Why Do I Care??  There are about 39 million migraine sufferers in the USA.  Among them about 4 million who suffers from chronic migraine lasting for 10-14 days.  The impact of migraine is more than the personal suffering; the US economy loses $36 billion yearly because of lost productivity linked to migraine.  While occasional migraine can be successfully treated with common medications, the chronic migraine sufferers don’t have a reliable treatment.

 

Plain English, Please!!!  First, let’s talk about migraine.  Migraine is a disorder of the central nervous system, and during a migraine attack the malfunctioning nervous system creates pain in the head area, visual disturbances (auras), and sometimes dizziness and nausea.   So, that’s why this disorder is so debilitating.

Second, let’s talk about pain, this warning signal of our nervous system.  We sense pain when tissue damage triggers nerve impulses in the nerve cells of the damaged body area, and those neurons conduct the nerve impulse to the brain.  Everyday pain killer drugs either block the action of chemical released during tissue damage, or they block the movement of the nerve impulse to the brain.

Third, let’s talk about this new treatment for migraine. Because migraine is not the result of tissue damage, common pain killers don’t work on chronic migraine pain.  Many years of research identified a chemical that trigger migraine pain; that chemical is called calcitonin gene related peptide (CGRP).  Migraine happens when CGRP reaches receptors on the neurons in the brain.   The receptor is like a wide receiver in football; the peptide has to be caught by the receptor to start migraine pain, like the wide receiver has to catch the football for a touchdown.  So, how can you block the action of that migraine-triggering peptide?  Imagine a football game where the arms of the wide receiver are duct taped to his body.  The drug erenumab does that to the receptor, so the CGRP peptide can not be caught by the receptor, so there is no more triggering of pain.  The duct tape, erenumab, can target CGRP receptors only, because erenumab is a modified antibody, a protein made by immune system cells to specifically target invaders in the body. As antibodies are proteins, they can not be taken orally, but have to be injected.

Powered by WordPress & Theme by Anders Norén